MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Akttyva Therapeutics
Akttyva Therapeutics

Akttyva Therapeutics is developing drugs that regulate the vascular permeability barrier, which is disrupted in >60 acute and chronic conditions. We target a key stress response pathway that restores the vascular barrier integrity using proprietary AI-assisted ML drug discovery platform. Akttyva's most advanced program is ARDS drug, with is 12 months from IND and we are looking for partnerships to develop drugs for other diseases based on this platform.
Akttyva Therapeutics is developing therapeutics for vascular leak disorders: ARDS, fibrosis.

Connect with Akttyva Therapeutics

2021

2021 Silver BOS-96

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.